NexgenRx Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced total revenue was CAD 2.651 million compared to CAD 2.237 million a year ago. Net income was CAD 509,843 compared to net loss of CAD 218,718 a year ago. Basic earnings per share from continuing operations was CAD 0.007 compared to basic loss per share from continuing operations of CAD 0.003 a year ago. For the nine months, total revenue was CAD 7.931 million compared to CAD 6.979 million a year ago. Net income was CAD 1.273 million compared to net loss of CAD 145,679 a year ago. Basic earnings per share from continuing operations was CAD 0.018 compared to basic loss per share from continuing operations of CAD 0.002 a year ago.